- Home
- KLTR vs VNDA Comparison
KLTR vs VNDA Comparison
Compare KLTR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTR
- VNDA
- Stock Information
- Founded
- KLTR 2006
- VNDA 2002
- Country
- KLTR United States
- VNDA United States
- Employees
- KLTR N/A
- VNDA N/A
- Industry
- KLTR EDP Services
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- KLTR Technology
- VNDA Health Care
- Exchange
- KLTR Nasdaq
- VNDA Nasdaq
- Market Cap
- KLTR 302.6M
- VNDA 260.0M
- IPO Year
- KLTR 2021
- VNDA 2006
- Fundamental
- Price
- KLTR $1.54
- VNDA $4.38
- Analyst Decision
- KLTR Strong Buy
- VNDA Strong Buy
- Analyst Count
- KLTR 2
- VNDA 3
- Target Price
- KLTR $3.50
- VNDA $14.00
- AVG Volume (30 Days)
- KLTR 1.8M
- VNDA 678.7K
- Earning Date
- KLTR 11-10-2025
- VNDA 10-29-2025
- Dividend Yield
- KLTR N/A
- VNDA N/A
- EPS Growth
- KLTR N/A
- VNDA N/A
- EPS
- KLTR N/A
- VNDA N/A
- Revenue
- KLTR $180,921,000.00
- VNDA $212,074,000.00
- Revenue This Year
- KLTR $3.47
- VNDA $14.32
- Revenue Next Year
- KLTR $2.54
- VNDA $37.05
- P/E Ratio
- KLTR N/A
- VNDA N/A
- Revenue Growth
- KLTR 1.88
- VNDA 11.12
- 52 Week Low
- KLTR $1.36
- VNDA $3.81
- 52 Week High
- KLTR $2.82
- VNDA $5.70
- Technical
- Relative Strength Index (RSI)
- KLTR 48.19
- VNDA 37.23
- Support Level
- KLTR $1.70
- VNDA $4.28
- Resistance Level
- KLTR $1.88
- VNDA $4.48
- Average True Range (ATR)
- KLTR 0.11
- VNDA 0.20
- MACD
- KLTR 0.01
- VNDA -0.04
- Stochastic Oscillator
- KLTR 26.23
- VNDA 9.56
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.